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Bacteria isolated from bloodstream infections at a tertiary hospital in Dar es 
Salaam, Tanzania – antimicrobial resistance of isolates
S Moyo, S Aboud, M Kasubi, S Y Maselle
Objective. A bloodstream infection (BSI) is a life-threatening 
condition. We studied the causative agents of BSIs and antimicrobial 
susceptibility patterns of bacterial isolates at Muhimbili National 
Hospital (MNH) in Dar es Salaam, Tanzania. 
Methods. A retrospective analysis of blood culture results obtained 
at MNH from January 2005 to December 2009 was done. Blood 
culture isolates judged to be clinically significant and antimicrobial 
susceptibility results of the bacteria were included. The frequencies 
and proportions of bacteria isolated and antimicrobial susceptibility 
results were analysed and compared using Pearson’s chi-square test 
and Fisher’s exact test where applicable, or the Mann-Whitney 
U-test. 
Results. A total of 13 833 blood cultures were performed. Bacterial 
pathogens were detected in 1 855 (13.4%), Gram-positive bacteria 
(1 523; 82.1%) being significantly more prevalent than Gram-
negative bacteria (332; 17.9%) (p=0.008). The most common 
bacterial pathogens isolated were coagulase-negative staphylococci 
(CoNS) (1 250; 67.4%), S. aureus (245; 13.2%), Escherichia coli (131; 
7%) and Klebsiella spp. (130; 7.0%). All bacteria isolated showed high 
resistance to penicillin G (70.6%), tetracycline (63.8%), cefotaxime 
(62.5%) and ampicillin (62.3%). Moderate to high resistance was 
seen against chloramphenicol (45.2%), erythromycin (35.0%), 
ciprofloxacin (29.3%), co-trimoxazole (25.0%) and gentamicin 
(23.5%). Of S. aureus isolates, 23.3% were resistant to methicillin. 
Conclusions. CoNS accounted for two-thirds of the bacterial 
pathogens isolated. High-level resistance was seen to first-line and 
inexpensive antimicrobial agents. Routine screening for extended-
spectrum beta-lactamase production and methicillin resistance 
among Gram-negative rods and S. aureus from blood cultures 
should be instituted to monitor spread of multidrug-resistant 
isolates. 
S Afr Med J 2010; 100: 835-838. 
A bloodstream infection (BSI) is a life-threatening condition that may 
be complicated by septic shock and death. BSI due to bacteria is an 
important cause of morbidity and mortality.1 Gram-negative bacteria 
have been associated with more deaths than Gram-positive bacteria.1 
Mortality due to septic shock can be as high as 60% despite treatment. 
A better understanding of the spectrum of pathogens causing BSI is 
crucial for prompt management of patients, as antimicrobial therapy 
greatly influences the outcome of patients with BSI.1 
Over the past 20 - 30 years there have been significant changes in 
the causation and epidemiology of BSI. While Staphylococcus aureus 
and Escherichia coli continue to be the most common causative 
agents, there has been a substantial increase in BSI due to coagulase-
negative staphylococci (CoNS). 
Recent studies have reported an increasing frequency of 
antimicrobial resistance among microbial pathogens causing BSI 
in Tanzania and elsewhere,2,3 and several classes of antimicrobial 
agents have become less effective as a result of the emergence of 
antimicrobial resistance, often caused by the selective pressure of 
antimicrobial usage. The important emerging problems are resistance 
to extended-spectrum cephalosporins and fluoroquinolones in the 
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Enterobacteriaceae, oxacillin resistance in staphylococci, penicillin 
resistance in streptococci, and vancomycin resistance in enterococci 
(and eventually staphylococci).2,4 The changing spectrum of microbial 
pathogens together with antimicrobial resistance trends and clinical 
significance necessitate continuous monitoring of antimicrobial 
resistance. Surveillance of antimicrobial resistance is critical in 
guiding physicians towards appropriate choice of antimicrobial 
agents to treat BSI. We aimed to describe the cauative agents and 
antimicrobial susceptibility patterns of bacterial isolates from patients 
with BSI. 
Methods 
The study was a retrospective analysis of blood cultures performed 
during the past 5 years (January 2005 - December 2009) at the 
Microbiology Section, Central Pathology Laboratory (CPL), 
Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. 
MNH is a tertiary health care facility handling patients with severe 
disease and those who require specialised management from three 
municipal hospitals in Dar es Salaam. All blood culture isolates 
that were detected and judged to be clinically significant, and 
antimicrobial drug susceptibility results of the bacteria isolated, were 
reviewed and included. Data including date of blood culture specimen 
collection, admitting hospital department (intensive care unit (ICU), 
paediatrics), blood culture and antimicrobial susceptibility results 
were recorded using a study data collection form. 
Bacterial isolation, identification and 
antimicrobial susceptibility testing
Micro-organisms were isolated and identified according to a standard 
operating procedure.5 Blood culture bottles received at the CPL were 
incubated aerobically at 37°C for 7 days. The bottles were examined 
daily for evidence of bacterial growth, haemolysis, gas production or 
turbidity above the red cell line. Subcultures using sterile syringes 
were done on blood agar, chocolate agar and MacConkey agar media 
daily for 7 days before blood cultures were reported as negative.6 For 
antimicrobial susceptibility, disc diffusion tests were performed for 
all the isolates according to the method recommended by the Clinical 
and Laboratory Standard Institute.7 Antibiotic disc (Oxoid) was 
applied to each plate, and after incubation at 35°C for 24 hours zone 
sizes were measured and interpreted accordingly.
Statistical analysis
Data were entered in Microsoft Excel 2000 (Microsoft Corp., 
Redmond, WA). The frequencies and proportions of bacteria isolated 
and antimicrobial susceptibility results were analysed. The data were 
also subjected to normality and homogeneity of variance tests. Where 
assumptions for parametric tests were not met, data were subjected 
to non-parametric tests and analysed using GraphPad InstantTM 
1990 - 1993 software. A p-value of <0.05 was regarded as statistically 
significant. 
Results 
During the 5-year period, a total of 13 833 blood cultures were 
performed, 8 682 (62.8%) from children and 5 151 (37.2%) from 
adults. Bacterial pathogens were detected in 1 855 (13.4%) of the 
cultures; of these 48.8% (906) were from children and 51.2% (949) 
from adults. Positive blood cultures were detected in only 33 blood 
specimens from the ICU (1.8%) compared with 1 822 (98.2%) from 
other wards. Gram-positive bacteria (1 523; 82.1%) were significantly 
more prevalent (p=0.008) than Gram-negative bacteria (332; 17.9%) 
(Fig. 1). 
The most common bacterial pathogens isolated were CoNS (1 250; 
67.4%), S. aureus (245; 13.2%), E. coli (131; 7%) and Klebsiella spp. 
(130; 7.0%). Other bacterial pathogens detected were Proteus spp. 
(34; 1.8%), Pseudomonas spp. (22; 1.2%), Streptococcus spp. (28; 
1.5%), Salmonella spp. (11; 0.6%), Enterobacter spp. (3; 0.2%) and 
Acinetobacter spp. 1 (0.1%) (Table I). Rates of detection of E. coli 
and Proteus spp. have been increasing over the years, while those of 
Klebsiella spp. and S. aureus have fluctuated in the past 5 years.
All bacteria isolated in our study showed a high level of resistance 
to the commonly used antimicrobial agents, including penicillin G 
(70.6%), tetracycline (63.8%), cefotaxime (62.5%) and ampicillin 
(62.3%). There were moderate to high levels of resistance to 
chloramphenicol (45.2%), erythromycin (35.0%), ciprofloxacin 
(29.3%), co-trimoxazole (25.0%) and gentamicin (23.5%). Gram-
positive bacteria showed a very low level of resistance to vancomycin 
(1.5%), whereas S. aureus showed moderate level (23.3%) of resistance 
to methicillin (Table II).
Discussion
Clinically significant BSI is associated with high morbidity and 
mortality and considerably impacts on health care costs, especially 
when caused by antimicrobial-resistant bacteria. In our study 13.4% 
Fig. 1. Prevalence of bacteraemia due to Gram-negative rods and Gram-
positive cocci from blood cultures at Muhimbili National Hospital, Dar es 
Salaam Tanzania, from 2005 to 2009.
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Table I. Bacteria isolated from blood cultures at Muhimbili 
National Hospital, Dar es Salaam, Tanzania, from 2005 to 
2009 
N % 
E. coli 131 7.1
Klebsiella spp. 130 7.0
Proteus spp. 34 1.8
Pseudomonas 22 1.2
Salmonella 11 0.6
Enterobacter 3 0.2
Acinetobacter 1 0.1
S. aureus 245 13.2
Streptococcus 28 1.5
CoNS 1 250 67.4
Total CP* 1 855 13.4‡
Total BL† 13 833
*Total total cultures positive.
†Total blood cultures collected.
‡Rate of bacteraemia (CP/BL) × 100. 
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of all blood cultures yielded positive results. The low rate may be 
explained by the fact that most patients probably received clinical 
care, including antimicrobial agents, at the municipal hospitals before 
admission to MNH, the referral hospital. Information on patients’ 
clinical history before referral, including the use of antimicrobial 
agents, was not available. 
Our study showed that Gram-positive bacteria (1 523; 82.1%) 
were significantly more prevalent than Gram-negative bacteria 
(332; 17.9%). These findings concur with those reported in previous 
studies in Tanzania and other African countries.8,9 The current shift 
from Gram-negative to Gram-positive bacteria in causing BSI has 
been explained by others.6 It has been suggested that this change is 
due to evolution of medical care, Gram-positive cocci having begun 
to re-emerge as predominant pathogens in BSI in the early 1980s.10 
The most commonly isolated bacteria in this study were CoNS, 
followed by S. aureus, E. coli and Klebsiella spp. Our findings are 
consistent with the results of other surveillance studies.9,11 CoNS 
are one of the most common causes of nosocomial BSI and also 
the most common blood culture contaminant.11 Because only one 
blood culture was obtained for each of our study patients, it was not 
possible to determine whether patients who had CoNS isolated had 
a true bacteraemia or the finding was due to skin contamination. 
It is also possible that the recovery of CoNS could have resulted 
from other factors such as prolonged use of invasive intravascular 
devices, prolonged hospital stay, or other underlying co-morbidities. 
However, other previous studies identified CoNS (37%) as the 
leading pathogens in BSI.10 The increased isolation of CoNS in blood 
cultures may also reflect a change from regarding these organisms 
as normal skin flora to viewing them as clinically significant. This 
is supported by the tremendous increase in the isolation of CoNS 
from 49 isolates in the year 2005 to 476 isolates in the year 2009. We 
therefore recommend that in our tertiary hospital guidelines should 
be provided to ensure that two sets of blood cultures are obtained to 
distinguish true CoNS bactaeremia from contamination. Hospital 
staff responsible for drawing blood for cultures should also receive 
training on aseptic technique.12 S. aureus was the most common 
pathogen detected, accounting for 13.2% of all positive blood 
cultures. 
Paediatric wards accounted for 62.8% of blood cultures in this 
study, but few strains of S. pneumoniae were recovered and there 
was no recovery of H. influenzae from children. These pathogens are 
common causes of invasive bacterial infections in an unvaccinated 
paediatric population.13-15 The World Health Organization (WHO) 
estimates that H. influenzae is the leading cause of bacterial meningitis 
in children under 5 years of age and the second leading cause of 
deaths due to bacterial pneumonia in resource-limited areas where 
vaccination is not performed.16,17 However, H. influenzae type B 
vaccination was introduced in 2009 and could not have influenced 
the current findings. It is possible that laboratory-prepared culture 
media made with human blood might inhibit or not support the 
growth of strains of H. influenzae. A laboratory surveillance system 
for S. pneumoniae and H. influenzae is needed as an important 
first step to determine the prevalence and incidence of invasive 
pneumococcal and H. influenzae infections, and to measure the 
impact of the introduction of vaccination. As noted, measures to 
build laboratory capacity will ultimately improve diagnostic and 
surveillance capabilities. 
Mortality and morbidity from BSI infections are greater when 
caused by antimicrobial-resistant bacteria, and proper treatment 
becomes a challenge.18 We observed resistance to several antimicrobial 
agents used for first-line and inexpensive treatment of BSI, such as 
ampicillin, co-trimoxazole, penicillin and gentamicin. This concurs 
with findings of Aboud et al., who reported resistance to first-line 
antibiotics among bacterial isolates from BSI in the same hospital.8 
We also documented high methicillin resistance among S. aureus; 
23.3% of our bloodstream isolates were resistant to methicillin. The 
methicillin-resistant S. aureus (MRSA) rate found in this study is 
higher than that reported 10 years ago from the same hospital (0.4%), 
and relatively higher than reported 5 years ago (12%).18,19 In Bugando 
referral hospital in northern Tanzania a prevalence of MRSA of 16.2% 
was reported,20 implying that there has been an increasing trend in 
MRSA spread in the country, as is the case worldwide. 
Table II. Antimicrobial resistance results of bacteria isolated from blood cultures at Muhimbili National Hospital, Dar es Salaam, 
from 2005 to 2009
 Gram-positive bacteria Gram-negative bacteria Total
 N %* N %* N %
Ampicillin 32 37.5 135 68.1 167 62.3
Gentamicin 50 26 214 22.9 264 23.5
Ciprofloxacin 158 42.4 154 15.6 312 29.3
Chloramphenicol 1 100 30 43.3 31 45.2
Erythromycin 189 34.4 14 42.9 203 35
Tetracycline 125 64.8 121 62.8 246 63.8
Penicillin G 174 68.9 13 92.3 187 70.6
Vancomycin† 135 1.5 - - 135 1.5
Cefotaxime‡ - - 8 62.5 8 62.5
Methicillin§ 103 23.3 - - 103 23.3
Co-trimoxazole 8 25 16 25 24 25
*Proportion of resistant isolates. 
†Tested against Gram-positives only. 
‡Tested against Gram-negatives only.
§Tested against S. aureus only.  
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Although not investigated in our study, bacteraemia due to 
MRSA is associated with high mortality compared with methicillin-
sensitive S. aureus bacteraemia.9 The Enterobacteriaceae in this 
study demonstrated a high level of resistance (62.5%) towards 
third-generation cephalosporins. Third-generation cephalosporin 
resistance is usually caused by expression of extended-spectrum beta-
lactamase (ESBL) enzymes, and this was probably the case among 
our strains, although specific confirmation of ESBL production 
was not performed. ESBL strains have been reported previously in 
septicaemic and ICU patients from the same hospital.2,3 
Lack of enforcement of mechanisms regulating antibiotic use as 
a part of infection control programmes could have influenced the 
pattern of resistance results to a considerable degree. In addition, 
there are no guidelines to isolate hospitalised patients found to carry 
MRSA or ESBL producing strains. This situation in part explains 
the increased spreading of MRSA and ESBL strains observed in this 
study. 
Conclusions
CoNS accounted for two-thirds of the bacterial pathogens isolated 
in our study. A high level of resistance to first-line and inexpensive 
antimicrobial agents was seen. Routine screening for ESBL production 
and methicillin resistance among Gram-negative rods and S. aureus 
from blood cultures should be instituted to monitor spread of 
multidrug-resistant isolates. 
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